2016 Breast Cancer CollectionBreast Cancer Ribbon

We invite you to explore The Oncologist's multidisciplinary collection of original research and reviews on advances in the diagnosis, pathology, and treatment of breast cancer. This collection covers diverse topics of interest to clinicians, including advances in genomic testing, biomarker analyses, and molecular classification, as well as treatment-related side effects, and outcome disparities.

Subscribe to our RSS feed to ensure you receive the latest in breast cancer research from The Oncologist.

Metastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at Massachusetts General Hospital

Aditya Bardia, John A. Iafrate, Tilak Sundaresan, Jerry Younger, and Valentina Nardi

The Oncologist 2016; 21:1035-1040; first published on August 22, 2016; doi:10.1634/theoncologist.2016-0240

Biology and Management of Patients With Triple-Negative Breast Cancer

Priyanka Sharma

The Oncologist 2016; 21:1050-1062; first published on July 11, 2016; doi:10.1634/theoncologist.2016-0067

Deciphering and Targeting Oncogenic Mutations and Pathways in Breast Cancer

Libero Santarpia, Giulia Bottai, Catherine M. Kelly, Balázs Gyõrffy, Borbala Székely, and Lajos Pusztai

The Oncologist 2016; 21:1063-1078; first published on July 6, 2016; doi:10.1634/theoncologist.2015-0369

A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial

Kimberly Blackwell, Roman Donskih, C. Michael Jones, Allen Nixon, Maria J. Vidal, Roumen Nakov, Pritibha Singh, Gregor Schaffar, Pere Gascón, and Nadia Harbeck

The Oncologist 2016; 21:789-794; first published on April 18, 2016; doi:10.1634/theoncologist.2016-0011

Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers

Haley Streff, Jessica Profato, Yuanqing Ye, Denise Nebgen, Susan K. Peterson, Claire Singletary, Banu K. Arun, and Jennifer K. Litton

The Oncologist 2016; 21:869-874; first published on June 15, 2016; doi:10.1634/theoncologist.2015-0354

Ventricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant Chemotherapy

Graeme J. Koelwyn, Nia C. Lewis, Susan L. Ellard, Lee W. Jones, Jinelle C. Gelinas, J. Douglass Rolf, Bernie Melzer, Samantha M. Thomas, Pamela S. Douglas, Michel G. Khouri, Neil D. Eves

The Oncologist 2016; 21:141-149; first published on January 13, 2016;doi:10.1634/theoncologist.2015-0352

Tamoxifen Initiation After Ductal Carcinoma In Situ

Hazel B. Nichols, Erin J.A. Bowles, Jessica Islam, Lawrence Madziwa, Til Stürmer, Diem-Thy Tran, and Diana S.M. Buist

The Oncologist 2016; 21:134-140; first published on January 14, 2016; doi:10.1634/theoncologist.2015-0310

Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications

Valeria Simone, Morena D'Avenia, Antonella Argentiero, Claudia Felici, Francesca Maria Rizzo, Giovanni De Pergola, Franco Silvestris

The Oncologist 2016; 21:404-417; first published on February 10, 2016; doi:10.1634/theoncologist.2015-0351

A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience

Megan J. McKee, Kevin Keith, Allison M. Deal, Amy L. Garrett, Amy A. Wheless, Rebecca L. Green, Julie M. Benbow, E. Claire Dees, Lisa A. Carey, Matthew G. Ewend, Carey K. Anders, Timothy M. Zagar

The Oncologist 2016; 21:16-20; first published on December 9, 2015; doi:10.1634/theoncologist.2015-0328

Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer

Kunal C. Kadakia, Claire F. Snyder, Kelley M. Kidwell, Nicholas J. Seewald, David A. Flockhart, Todd C. Skaar, Zereunesay Desta, James M. Rae, Julie L. Otte, Janet S. Carpenter, Anna M. Storniolo, Daniel F. Hayes, Vered Stearns, N. Lynn Henry

The Oncologist 2016; 21:539-546; first published on March 23, 2016; doi:10.1634/theoncologist.2015-0349

Cardiac Safety of Paclitaxel Plus Trastuzumab and Pertuzumab in Patients With HER2-Positive Metastatic Breast Cancer

Anthony F. Yu, Carlos Manrique, Shawn Pun, Jennifer E. Liu, Elton Mara, Martin Fleisher, Sujata Patil, Lee W. Jones, Richard M. Steingart, Clifford A. Hudis, Chau T. Dang

The Oncologist 2016; 21:418-424; first published on March 16, 2016; doi:10.1634/theoncologist.2015-0321

Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3)

Sunil Verma, Cynthia Huang Bartlett, Patrick Schnell, Angela M. DeMichele, Sherene Loi, Jungsil Ro, Marco Colleoni, Hiroji Iwata, Nadia Harbeck, Massimo Cristofanilli, Ke Zhang, Alexandra Thiele, Nicholas C. Turner, Hope S. Rugo

The Oncologist 2016; 21:1165-1175; first published on July 1, 2016; doi:10.1634/theoncologist.2016-0097

Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment

Marie Lange, Natacha Heutte, Olivier Rigal, Sabine Noal, Jean-Emmanuel Kurtz, Christelle Lévy, Djelila Allouache, Chantal Rieux, Johan Lefel, Bénédicte Clarisse, Corinne Veyret, Philippe Barthélémy, Nadine Longato, Hélène Castel, Francis Eustache, Bénédicte Giffard, and Florence Joly

The Oncologist 2016; 21:1337-1348; first published on July 29, 2016; doi:10.1634/theoncologist.2016-0014

High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer

Emilio Alba, Ana Lluch, Nuria Ribelles, Antonio Anton-Torres, Pedro Sanchez-Rovira, Joan Albanell, Lourdes Calvo, Jose Antonio Lopez García-Asenjo, Jose Palacios, Jose Ignacio Chacon, Amparo Ruiz, Juan De la Haba-Rodriguez, Miguel A. Segui-Palmer, Beatriz Cirauqui, Mireia Margeli, Arrate Plazaola, Agusti Barnadas, Maribel Casas, Rosalia Caballero, Eva Carrasco, Federico Rojo

The Oncologist 2016; 21:150-155; first published on January 19, 2016; doi:10.1634/theoncologist.2015-0312

Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives

Alessandro Inno, Giuseppe Bogina, Monica Turazza, Laura Bortesi, Simona Duranti, Alberto Massocco, Giuseppe Zamboni, Giovanni Carbognin, Filippo Alongi, Matteo Salgarello, Stefania Gori

The Oncologist 2016; 21:28-32; first published on December 9, 2015; doi:10.1634/theoncologist.2015-0309